Article info

Download PDFPDF
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer

Authors

  1. Address for correspondence: Paul Sevelda, M.D., 1st Department of Gynaecology & Obstetrics, University of Vienna, Spitalgasse 23, A-1090 Vienna, Austria.

Citation

Sevelda P, Vavra N, Fitz R, et al
Goserelin a GnRH-analogue as third-line therapy of refractory epithelial ovarian cancer

Publication history

  • First published April 1, 1992.
Online issue publication 
March 04, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.